Original language | English |
---|---|
Pages (from-to) | 23-31 |
Number of pages | 9 |
Journal | Pharmacoeconomics (Online) |
Volume | 34 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2016 |
Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene
Hedwig Blommestein, N Armstrong, S Ryder, S Deshpande, G Worthy, C Noake, R Riemsma, J Kleijnen, Hans Severens, Maiwenn Al
Research output: Contribution to journal › Article › Academic › peer-review
3
Citations
(Scopus)
7
Downloads
(Pure)